ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,666Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 45

$713K Total Retail Price of All Prescriptions

Rank: 14 out of 45

735 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 735 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 735 patients filled at least one prescription for a schedule three drug, compared to an average of 25%.

Risky Drugs to Seniors

2% of this provider’s 11,007 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SIMVASTATIN 593 527 1 4
HYDROCODONE-ACETAMINOPHEN 542 420 S3 2 1
LISINOPRIL 423 381 3 2
LOVASTATIN 379 333 4 49
AMLODIPINE BESYLATE 349 321 5 7
LEVOTHYROXINE SODIUM 337 317 6 5
METFORMIN HCL 327 278 7 8
FUROSEMIDE 318 302 8 6
METOPROLOL SUCCINATE 309 303 9 18
HYDROCHLOROTHIAZIDE 232 218 10 11
OMEPRAZOLE 224 201 11 3
SERTRALINE HCL 211 174 12 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 208 187 13 29
ATORVASTATIN CALCIUM 197 188 14 12
METOPROLOL TARTRATE 179 174 15 10
ZOLPIDEM TARTRATE 168 91 16 22
AMLODIPINE BESYLATE-BENAZEPRIL 167 150 17 77
WARFARIN SODIUM 162 148 18 17
GABAPENTIN 150 119 19 9
PROMETHAZINE HCL 130 111 R 20 33
MELOXICAM 128 112 21 28
ALENDRONATE SODIUM 126 126 22 62
CITALOPRAM HBR 119 100 23 21
NEXIUM 119 97 23 19
LOSARTAN POTASSIUM 118 96 25 27
CRESTOR 113 81 26 23
ALLOPURINOL 112 100 27 36
DONEPEZIL HCL 111 111 28 37
ISOSORBIDE MONONITRATE ER 106 106 29 30
POTASSIUM CHLORIDE 99 99 30 13
PANTOPRAZOLE SODIUM 87 76 31 31
TAMSULOSIN HCL 85 75 32 34
DIOVAN HCT 83 74 33 122
LOSARTAN-HYDROCHLOROTHIAZIDE 82 78 34 96
NAMENDA 79 79 35 57
DICLOFENAC SODIUM 78 75 36 80
GLIMEPIRIDE 75 71 37 72
ACETAMINOPHEN-CODEINE 74 65 S3 38 66
LACTULOSE 73 72 39 81
ATENOLOL 72 58 40 15
PRAVASTATIN SODIUM 71 67 41 14
CARVEDILOL 69 68 42 25
CLOPIDOGREL 69 59 42 26
VENLAFAXINE HCL ER 66 58 44 93
HYDRALAZINE HCL 65 61 45 108
PLAVIX 63 58 46 35
LORAZEPAM 60 55 47 192
TRAZODONE HCL 53 39 48 32
DOXAZOSIN MESYLATE 53 48 48 67
SPIRIVA 53 52 48 54
BENAZEPRIL HCL 51 38 51 75
CELEBREX 51 49 51 110
PAROXETINE HCL 50 42 53 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.